COLD START / catalog / c/lifescivcretrieved 2026-08-18T22:09 UTC · 23 sources read

LifeSciVC

LifeSciVC is Bruce Booth's blog on early-stage biotech venture capital, financing, and drug discovery.

lifescivc.com · Wellesley

CALL NO.CS·LIFESCIVC·26

StageReported financingno source in ledger[4]

Raisednot publicly disclosedno source in ledger

Headcountnot publicly disclosedno source in ledger

Valuationnot publicly disclosedno source in ledger

Foundednot publicly disclosedno source in ledger

Money

Reported financing.[4]

post-money valuation and the full investor list are not publicly disclosed.

People

Bruce Booth, Author and partner at Atlas Venture[9][14][18]

Signals

Aug 18 2026newsLifeSciVC - Bruce Booth, partner at Atlas Venture, blogs on all ... company claim, not independently confirmed[9]

Aug 18 2026newsTwenty Years In Early Stage Biotech VC (Part 3): Business company claim, not independently confirmed[19]

Oct 15 2025otherTwenty Years In Early Stage Biotech VC (Part 2): People company claim, not independently confirmed[15]

Jul 8 2025otherLeadership in the Age of Stacks company claim, not independently confirmed[16]

Jul 31 2024otherA Primer on Early-Stage Biotech VC company claim, not independently confirmed[11]

Apr 26 2024newsThe Biotech Startup Contraction Continues... And That's A ... company claim, not independently confirmed[20]

Risk

The customer proof is company-sourced only. No independent source in this ledger confirms it.[9]

Next question

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.

Sourcestracings · 23

[1]Biotech Venture Ecosystem: Quick Health Check - LifeSciVC

Aug 2026 · lifescivc.com

company

[2]Biotech Venture Deal Terms Are More "Startup-Friendly" Than Ever - LifeSciVC

Aug 2026 · lifescivc.com

company

[3]The Record-Breaking Biotech Funding Tsunami Of 1H2020 - LifeSciVC

Aug 2026 · lifescivc.com

company

[4]Raising Capital As A Private Biotech: Insights From Unum Therapeutics' Series B Round - LifeSciVC

Aug 2026 · lifescivc.com

company

[5]Life Science Venture Financing Terms: Favorable Five Year Trends - LifeSciVC

Aug 2026 · lifescivc.com

company

[6]Another Trophy Quarter For VC-Backed Biotech Funding - LifeSciVC

Aug 2026 · lifescivc.com

company

[7]Venture Volatility: 2018's Banner Year Closed Cautiously - LifeSciVC

Aug 2026 · lifescivc.com

company

[8]It's Raining Biotech SPACs! - LifeSciVC

Aug 2026 · lifescivc.com

company

[9]LifeSciVC - Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech

Aug 2026 · lifescivc.com

company

[10]Five Years Into the LifeSciVC Experiment

Aug 2026 · lifescivc.com

company

[11]A Primer on Early-Stage Biotech VC - LifeSciVC

Aug 2026 · lifescivc.com

company

[12]Deconstructing the Diligence Process: An Approach to Vetting New Product Theses

Aug 2026 · lifescivc.com

company

[13]How's My Baby? - LifeSciVC

Aug 2026 · lifescivc.com

company

[14]About Bruce Booth

Aug 2026 · lifescivc.com

company

[15]Twenty Years In Early Stage Biotech VC (Part 2): People

Aug 2026 · lifescivc.com

company

[16]Leadership in the Age of Stacks - LifeSciVC

Aug 2026 · lifescivc.com

company

[17]Leadership Archives - LifeSciVC

Aug 2026 · lifescivc.com

company

[18]org_enrichment

Aug 2026

vendor

[19]Twenty Years In Early Stage Biotech VC (Part 3): Business

Aug 2026 · lifescivc.com

company

[20]The Biotech Startup Contraction Continues... And That's A ...

Aug 2026 · lifescivc.com

company

[21]Hiring In A Syndemic - LifeSciVCLifeSciVC

Aug 2026 · lifescivc.com

company

[22]About Me - LifeSciVCLifeSciVC

Aug 2026 · lifescivc.com

company

[23]“A Tale of Two Sentiments: JPM 2025” | Bruce Booth

Aug 2026 · linkedin.com

vendor

LifeSciVC is Bruce Booth's blog on early-stage biotech venture capital, financing, and drug discovery.

lifescivc.com · Wellesley

StageReported financing

Raisednot publicly disclosed

Headcountnot publicly disclosed

Valuationnot publicly disclosed

Foundednot publicly disclosed

Compsnone named by a source

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.